Association between variation in the vesicular monoamine transporter 1 gene on chromosome 8p and anxiety-related personality traits

Neuroscience Letters

Volumn 434, Issue 1, 2008, Pages 41-45

  Lohoff, Falk W ^a   Lautenschlager, Marion ^b   Mohr, Johannes ^b,c   Ferraro, Thomas N ^a   Sander, Thomas ^d   Gallinat, Jürgen ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c BERNSTEIN CENTER FOR COMPUTATIONAL NEUROSCIENCE   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Genetics; Healthy volunteers; Personality; QTL; SLC18A1 polymorphism; STAI; State and Trait Anxiety Inventory; VMAT1

Indexed keywords

ISOLEUCINE; THREONINE; VESICULAR MONOAMINE TRANSPORTER 1;

ADULT; ANXIETY; ANXIETY DISORDER; ARTICLE; CHROMOSOME 8P; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PERSONALITY TEST; PRIORITY JOURNAL; SEX DIFFERENCE; STATE TRAIT ANXIETY INVENTORY;

ADULT; ANXIETY DISORDERS; BIOGENIC MONOAMINES; BRAIN; BRAIN CHEMISTRY; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; MUTATION, MISSENSE; PERSONALITY; POLYMORPHISM, GENETIC; SEX FACTORS; VARIATION (GENETICS); VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 40649105474     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.01.024     Document Type: Article

References (49)

1. Aleman A., Kahn R.S., and Selten J.P. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch. Gen. Psychiatry 60 (2003) 565-571
2. Almasy L., and Blangero J. Endophenotypes as quantitative risk factors for psychiatric disease: rationale and study design. Am. J. Med. Genet. 105 (2001) 42-44
3. Aston-Jones G., Rajkowski J., and Cohen J. Role of locus coeruleus in attention and behavioral flexibility. Biol. Psychiatry 46 (1999) 1309-1320
4. Barbato G.F., and Kruzelock R.P. Heterosis for concentrations of dopamine, norepinephrine, their metabolites, and epinephrine in the chick hyperstriatum ventrale, hypothalamus, and optic tectum. Behav. Genet. 22 (1992) 381-398
5. Barnes L.L.B., Harp D., and Jung W.S. Reliability generalization of scores on the Spielberger State-Trait Anxiety Inventory. Educ. Psychol. Meas. 62 (2002) 603-618
6. Barnett J.H., Heron J., Ring S.M., Golding J., Goldman D., Xu K., and Jones P.B. Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am. J. Psychiatry 164 (2007) 142-149
7. Berrettini W. Bipolar disorder and schizophrenia: convergent molecular data. Neuromol. Med. 5 (2004) 109-117
8. Bly M. Mutation in the vesicular monoamine gene, SLC18A1, associated with schizophrenia. Schizophr. Res. 78 (2005) 337-338
9. Brunk I., Blex C., Rachakonda S., Holtje M., Winter S., Pahner I., Walther D.J., and Ahnert-Hilger G. The first luminal domain of vesicular monoamine transporters mediates G-protein-dependent regulation of transmitter uptake. J. Biol. Chem. 281 (2006) 33373-33385
10. Charney D.S., and Deutch A. A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. Crit. Rev. Neurobiol. 10 (1996) 419-446
11. Chen S.F., Chen C.H., Chen J.Y., Wang Y.C., Lai I.C., Liou Y.J., and Liao D.L. Support for association of the A277C single nucleotide polymorphism in human vesicular monoamine transporter 1 gene with schizophrenia. Schizophr. Res. 90 (2007) 363-365
12. Cloninger C.R., Svrakic D.M., and Przybeck T.R. A psychobiological model of temperament and character. Arch. Gen. Psychiatry 50 (1993) 975-990
13. Cloninger C.R., Van Eerdewegh P., Goate A., Edenberg H.J., Blangero J., Hesselbrock V., Reich T., Nurnberger Jr. J., Schuckit M., Porjesz B., Crowe R., Rice J.P., Foroud T., Przybeck T.R., Almasy L., Bucholz K., Wu W., Shears S., Carr K., Crose C., Willig C., Zhao J., Tischfield J.A., Li T.K., and Conneally P.M. Anxiety proneness linked to epistatic loci in genome scan of human personality traits. Am. J. Med. Genet. 81 (1998) 313-317
14. Comings D.E. Molecular heterosis as the explanation for the controversy about the effect of the DRD2 gene on dopamine D2 receptor density. Mol. Psychiatry 4 (1999) 213-215
15. Comings D.E., and MacMurray J.P. Molecular heterosis: a review. Mol. Genet. Metab. 71 (2000) 19-31
16. Comings D.E., MacMurray J.P., Gonzalez N., Ferry L., and Peters W.R. Association of the serotonin transporter gene with serum cholesterol levels and heart disease. Mol. Genet. Metab. 67 (1999) 248-253
17. Costa Jr. P.T., Terracciano A., and McCrae R.R. Gender differences in personality traits across cultures: robust and surprising findings. J. Pers. Soc. Psychol. 81 (2001) 322-331
18. Dina C., Nemanov L., Gritsenko I., Rosolio N., Osher Y., Heresco-Levy U., Sariashvilli E., Bachner-Melman R., Zohar A.H., Benjamin J., Belmaker R.H., and Ebstein R.P. Fine mapping of a region on chromosome 8p gives evidence for a QTL contributing to individual differences in an anxiety-related personality trait: TPQ harm avoidance. Am. J. Med. Genet. B Neuropsychiatr. Genet. 132 (2005) 104-108
19. Du L., Bakish D., and Hrdina P.D. Gender differences in association between serotonin transporter gene polymorphism and personality traits. Psychiatr. Genet. 10 (2000) 159-164
20. Ebstein R.P. The molecular genetic architecture of human personality: beyond self-report questionnaires. Mol. Psychiatry 11 (2006) 427-445
21. Erickson J.D., Schafer M.K., Bonner T.I., Eiden L.E., and Weihe E. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5166-5171
22. Farmer A., Mahmood A., Redman K., Harris T., Sadler S., and McGuffin P. A sib-pair study of the temperament and character inventory scales in major depression. Arch. Gen. Psychiatry 60 (2003) 490-496
23. Fountoulakis K.N., Papadopoulou M., Kleanthous S., Papadopoulou A., Bizeli V., Nimatoudis I., Iacovides A., and Kaprinis G.S. Reliability and psychometric properties of the Greek translation of the State-Trait Anxiety Inventory form Y: preliminary data. Ann. Gen. Psychiatry 5 (2006) 2
24. Gallinat J., Mulert C., Bajbouj M., Herrmann W.M., Schunter J., Senkowski D., Moukhtieva R., Kronfeldt D., and Winterer G. Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. Neuroimage 17 (2002) 110-127
25. Goodwin R.D., and Gotlib I.H. Gender differences in depression: the role of personality factors. Psychiatry Res. 126 (2004) 135-142
26. Heslop K.E., and Curzon G. Effect of reserpine on behavioural responses to agonists at 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C receptor subtypes. Neuropharmacology 38 (1999) 883-891
27. Joels M. Corticosteroid effects in the brain: U-shape it. Trends Pharmacol. Sci. 27 (2006) 244-250
28. Kirchheiner J., Lang U., Stamm T., Sander T., and Gallinat J. Association of CYP2D6 genotypes and personality traits in healthy individuals. J. Clin. Psychopharmacol. 26 (2006) 440-442
29. Lander E.S., and Schork N.J. Genetic dissection of complex traits. Science 265 (1994) 2037-2048
30. Lang U.E., Hellweg R., Kalus P., Bajbouj M., Lenzen K.P., Sander T., Kunz D., and Gallinat J. Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) 180 (2005) 95-99
31. Lee H.S. Gender-specific molecular heterosis and association studies: dopamine D2 receptor gene and smoking. Am. J. Med. Genet. B Neuropsychiatr. Genet. 118 (2003) 55-59
32. Leung A., and Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr. Scand. Suppl. 401 (2000) 3-38
33. Lohoff F.W., Dahl J.P., Ferraro T.N., Arnold S.E., Gallinat J., Sander T., and Berrettini W.H. Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar I disorder. Neuropsychopharmacology 31 (2006) 2739-2747
34. Lynn R., and Martin T. Gender differences in extraversion, neuroticism, and psychoticism in 37 nations. J. Soc. Psychol. 137 (1997) 369-373
35. Mizuno T., Aoki M., Shimada Y., Inoue M., Nakaya K., Takahashi T., Itoyama Y., Kanazawa M., Utsumi A., Endo Y., Nomura T., Hiratsuka M., Mizugaki M., Goto J., Hongo M., and Fukudo S. Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety. J. Psychosom. Res. 60 (2006) 91-97
36. Peter D., Finn J.P., Klisak I., Liu Y., Kojis T., Heinzmann C., Roghani A., Sparkes R.S., and Edwards R.H. Chromosomal localization of the human vesicular amine transporter genes. Genomics 18 (1993) 720-723
37. Peter D., Liu Y., Sternini C., de Giorgio R., Brecha N., and Edwards R.H. Differential expression of two vesicular monoamine transporters. J. Neurosci. 15 (1995) 6179-6188
38. Pooley E.C., Fairburn C.G., Cooper Z., Sodhi M.S., Cowen P.J., and Harrison P.J. A 5-HT2C receptor promoter polymorphism (HTR2C-759C/T) is associated with obesity in women, and with resistance to weight loss in heterozygotes. Am. J. Med. Genet. B Neuropsychiatr. Genet. 126 (2004) 124-127
39. Ramanaiah N.V., Franzen M., and Schill T. A psychometric study of the State-Trait Anxiety Inventory. J. Pers. Assess. 47 (1983) 531-535
40. Richards M., Iijima Y., Kondo H., Shizuno T., Hori H., Arima K., Saitoh O., and Kunugi H. Association study of the vesicular monoamine transporter 1 (VMAT1) gene with schizophrenia in a Japanese population. Behav. Brain Funct. 2 (2006) 39
41. Savitz J.B., and Ramesar R.S. Personality: is it a viable endophenotype for genetic studies of bipolar affective disorder?. Bipolar Disord. 8 (2006) 322-337
42. Senkowski D., Linden M., Zubragel D., Bar T., and Gallinat J. Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. Biol. Psychiatry 53 (2003) 304-314
43. Sievert M.K., and Ruoho A.E. Peptide mapping of the [125I]Iodoazidoketanserin and [125I]2-N-[(3′-iodo-4′-azidophenyl)propionyl]tetrabenazine binding sites for the synaptic vesicle monoamine transporter. J. Biol. Chem. 272 (1997) 26049-26055
44. Slattery D.A., Hudson A.L., and Nutt D.J. Invited review: the evolution of antidepressant mechanisms. Fundam. Clin. Pharmacol. 18 (2004) 1-21
45. C. Spielberger, State-Trait Anxiety Inventory: A Comprehensive Bibliography, 1989.
46. Tsai S.J., Hong C.J., Yu Y.W., and Chen T.J. Association study of catechol-O-methyltransferase gene and dopamine D4 receptor gene polymorphisms and personality traits in healthy young chinese females. Neuropsychobiology 50 (2004) 153-156
47. Zheng G., Dwoskin L.P., and Crooks P.A. Vesicular monoamine transporter 2: role as a novel target for drug development. AAPS J. 8 (2006) E682-E692
48. Zohar A.H., Dina C., Rosolio N., Osher Y., Gritsenko I., Bachner-Melman R., Benjamin J., Belmaker R.H., and Ebstein R.P. Tridimensional personality questionnaire trait of harm avoidance (anxiety proneness) is linked to a locus on chromosome 8p21. Am. J. Med. Genet. B Neuropsychiatr. Genet. 117 (2003) 66-69
49. Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R. and Dunbar, G.C., The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, J Clin Psychiatry, 59 Suppl 20 (1998) 22-33;quiz 34-57.